$32.98 – $204.98
Earn 33 - 205 points upon purchasing this product.
A recent study utilizing mice with GH receptor KO gene showed that IGF-1 administration stimulates the growth (width) of the tibial growth plate and that IGF-1 has a GH independent effect on the growth plate. These findings are similar to those found when treating hypophysectomised rats with IGF-1 [R].
IGF-1 LR3 Research Peptide
Peptides are short chains of amino acid sequence that are naturally produced in the body and are involved in controlling various functions, including cell division. In therapy, peptides can be used to modify existing amino acid sequences and mimic or replace natural peptides to regulate cellular functions. Peptides have the potential to improve homeostasis, repair, and anabolism in the body. They can attach to other cells and tell them what to do, imitating or replacing the functions of the natural peptide. Peptides have been studied in mammalian cell cultures and have been found to affect stem cell progeny and generic stem cells.
IGF1 LR3 Receptor Grade is a synthetic, highly purified variant of the Insulin-like Growth Factor 1 (IGF1) hormone with a prolonged half-life. It is extensively characterized and produced using strict quality control standards to ensure its potency and consistency. IGF1 LR3 Receptor Grade is frequently utilized in scientific research to examine IGF1’s effects on growth and development.
On the market, there are two grades of IGF1 LR3: Receptor Grade and Media Grade. Here are some important distinctions between the two:
IGF1 LR3 (Insulin-like growth factor 1 Long R3) Receptor Grade functions by binding to the IGF-1 cell surface receptors , thereby initiating a cascade of intracellular signaling events that promote cell growth, proliferation, and differentiation. IGF-1 LR3 is a modified form of the naturally occurring IGF-1 protein that has a longer half-life and is more resistant to degradation, allowing for a more sustained level of activity within the body.
When IGF1 LR3 Receptor Grade binds to the IGF-1 receptor, it activates a number of intracellular signaling pathways, including the PI3K-Akt pathway and the MAPK/ERK pathway, which promote protein synthesis, cell growth, and survival. These signaling pathways can also enhance glucose uptake and metabolism, resulting in increased energy and enhanced physical performance.
Multiple animal and cell-based studies have been conducted on IGF1 LR3 Receptor Grade. This research chemical has also been the subject of clinical research. All these pieces of research have shown that IGF1 LR3 Receptor Grade can potential to increase muscle mass, prevent breast cancer growth, offer neuroprotection, and promote renal blood flow.
However, in the absence of randomized, large-scale, placebo-controlled trials, the FDA is yet to approve IGF1 LR3 Receptor Grade for human consumption. Therefore, Behemoth Labz sells IGF1 LR3 Receptor Grade for laboratory and research purposes, not for human use.
Without randomized, large-scale, placebo-controlled trials, the FDA has not approved IGF1 LR3 Receptor Grade for human consumption. Thus, Behemoth Labz sells IGF1 LR3 Receptor Grade for research only.
Insulin-like growth factor-1 (IGF-1) is a protein that is minimally produced in the adult human kidney. However, its receptor is expressed in abundance on proximal tubule cells of the kidney. Following kidney injury, the surviving proximal tubule cells increase their expression of IGF-1, and inflammatory cells recruited to the site of injury, such as macrophages, also produce IGF-1. IGF-1 has been shown to have several beneficial effects on the kidney, including promoting renal blood flow and increasing the glomerular filtration rate. It can also induce the expression of the epidermal growth factor receptor (EGFR), which may enhance the cell proliferation of remaining tubular cells through EGFR signaling. Moreover, IGF-1 can promote anabolism and protein synthesis, which may aid in recovery from acute illness. However, despite promising results in animal studies, clinical trials in humans have failed to demonstrate a benefit of IGF-1.[R]
Numerous studies were conducted to determine the connection between IGF-I, insulin sensitivity, and type 2 diabetes. IGF-I is produced in the liver in response to growth hormone and is typically bound to a circulating protein. Low IGF-I levels have been linked to an increased risk of insulin receptor resistance, metabolic syndrome, and type 2 diabetes, but a recent study found a U-shaped relationship between IGF-I levels and the risk of developing type 2 diabetes. This suggests that both low and high levels of IGF-I may increase the risk of developing type 2 diabetes. [R]
There is a need for further research to clarify this relationship and determine its potential clinical implications. The potential mechanisms underlying the effects of IGF-I on decreased insulin sensitivity and glucose homeostasis, including the role of IGF-binding proteins and other regulatory factors, should also be investigated in future studies.
In an investigation of the effects of the insulin-like growth factor-1/binding protein-3 (IGF-1/BP-3) protein complex on muscle wasting (muscle tissue atrophy) in rats, two groups of rats were examined. The IGF-1/BP-3 complex was administered to one group, while the other group received no treatment. Both groups of rats were evaluated for muscle mass, muscle fiber size, and levels of proteins associated with muscle cells growth and breakdown.
In comparison to untreated rats, rats treated with IGF-1/BP-3 exhibited less muscle wasting and larger muscle fiber size. Additionally, the treated rats had higher concentrations of proteins that promote muscle growth and lower concentrations of proteins that promote muscle breakdown.
The study indicates that the IGF-1/BP-3 complex may have a positive effect on muscle atrophy or muscle wastage diseases by promoting muscle growth and decreasing muscle breakdown. However, additional research is required to confirm these results and determine whether or not this treatment could be effective in humans.
A study was conducted to investigate the association between insulin-like growth factor-1 (IGF-1) hormone and the risk of developing Alzheimer’s disease (AD) and changes in brain volume. The research was conducted on a group of people who did not have dementia, ranging from middle-aged to older. Blood samples were taken at different times and MRI scans were used to analyze brain volume. The study revealed that individuals with lower IGF-1 levels had a greater risk of developing AD, while those with higher levels had larger brain volumes, even among middle-aged individuals who had no history of stroke or dementia. The findings suggest that higher levels of IGF-1 may provide protection against neurodegeneration.
Insulin-like growth factor (IGF) is a hormone that helps cells grow and develop in the body. But when it comes to cancer cells, high levels of IGF can help them grow, stay alive, and stop responding to treatment. This is because cancer cells often have mutations that cause them to make more IGF receptors than normal cells. This gives cancer cells a stronger response to IGF signals than normal cells.
When cancer cells are exposed to a lot of IGF, they start a complicated signaling process that makes the cells grow and divide. This can lead to the growth of new blood vessels that bring nutrients and oxygen to the growing tumor. It can also help cancer cells hide from the immune system.
IGF can also mess with cell death (called apoptosis), which makes cancer cells more resistant to chemotherapy and other treatments. Studies have shown that drugs that target IGF signaling pathways can stop the growth of cancer cells and make other treatments work better. [R]
IGF1 LR3 Receptor Grade has a half-life of approximately 20 to 30 hours. This is considerably longer than the natural half-life of IGF-1, which is only a few minutes. IGF1 LR3 Receptor Grade has an extended half-life as a result of its modification, which involves replacing the last three amino acids of the IGF-1 protein with arginine and adding 13 amino acids to the N-terminus. These modifications increase the binding affinity of IGF-1 to its receptor and protect it from protease degradation, resulting in a longer-lasting and more potent effect within the body.
The US Food and Drug Administration (FDA) and the European Medicines Agency have not approved IGF1 LR3 (Insulin-like growth factor 1 Long R3) Receptor Grade for human use (EMA). Possession, distribution, and use of IGF1 LR3 Receptor Grade without a prescription are therefore prohibited in a number of nations, including the United States.
IGF1 LR3 Receptor Grade is a Schedule III controlled substance in the United States, which indicates that it has a moderate to low potential for abuse and can cause physical or psychological dependence. Many sports organizations prohibit the use of IGF1 LR3 Receptor Grade for non-medical purposes, such as bodybuilding or athletic performance enhancement, as doping.
Behemoth Labz is the best place to buy IGF1 LR3 Receptor Grade online.
We have been around since 2014, supplying the highest-quality research compounds money can buy. All of our products come with a 100% satisfaction guarantee, free shipping, and a money-back guarantee.
The IGF1 LR3 Receptor Grade is a synthetic, highly purified variant of the Insulin-like Growth Factor 1 (IGF1) hormone with a prolonged half-life, used in scientific research to examine IGF1’s effects on growth and development. This hormone binds to the IGF-1 receptor on the surface of cells, promoting cell growth, proliferation, and differentiation by activating a cascade of intracellular signaling events. IGF1 LR3 Receptor Grade is being studied for its potential to increase muscle mass, prevent breast cancer growth, offer neuroprotection, and promote renal blood flow. However, without randomized, large-scale, placebo-controlled trials, the FDA has not approved IGF1 LR3 Receptor Grade for human consumption, and it is sold only for laboratory and research purposes.
Please make sure you go through the Terms and Conditions, and please familiarize yourself with it as it is important. Please research the scientific uses of this product before making any purchases. Make note that the packaging and labels of the product may differ from those shown on the website.
Buying the product means you agree with our Terms and Conditions. You can contact our awesome customer service team at firstname.lastname@example.org if you are not fully satisfied with the product. Customer satisfaction is our number one priority!
ATTENTION: All BehemothLabz products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY. They are not to be used for any human and veterinary purposes.
I’ve been a long time customer and you guys never failed me. I always received my stuff on time. And thank you for the daily updates. Thumbs Up!
Damian Stick –
Your products are getting better every year. But the shipping took almost forever. I hope it will be better next time around.
Benson Yatfield –
Perfect for my research! This product is really helpful.
Halle K –
This has really helped me lose stubborn fat, I also gained energy.
Albert Peterson –
In the two weeks I’ve been using it, I’ve lost significant pounds and noticed a huge improvement in my muscle quality.
Jameson Mayer –
Order came in without a hitch. Easy process and great stuff!
The quality of your products are unmatched by any other company I have bought from, you guys are my new go to.
Cleo Casper –
Great products and the discount was great.
Happy with my test results.
Roger Thompson –
It definitely helps me get through tough workouts without getting tired or crashing at the end. I will definitely continue using.
B. Kelly –
M Macejkovic –
Gabriel Snow –
Great quality product, i can really see how this is boosting my results, very happy.
This is great and doesn’t give you any weird side effects like other products. Definitely recommend!